Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants. by Reddy, BG, Silk, J, Salio, M, Balamurugan, R, Shepherd, D, Ritter, G, Cerundolo, V, Schmidt, R

Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells. by Silk, J, Salio, M, Reddy, BG, Shepherd, D, Gileadi, U, Brown, J, Masri, S, Polzella, P, Ritter, G, Besra, G, Jones, E, Schmidt, R, Cerundolo, V

Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells by Silk, J, Salio, M, Reddy, BG, Shepherd, D, Gileadi, U, Brown, J, Masri, S, Polzella, P, Ritter, G, Besra, G, Jones, E, Schmidt, R, Cerundolo, V

The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. by McCarthy, C, Shepherd, D, Fleire, S, Stronge, V, Koch, M, Illarionov, P, Bossi, G, Salio, M, Denkberg, G, Reddington, F, Tarlton, A, Reddy, BG, Schmidt, R, Reiter, Y, Griffiths, G, Van Der Merwe, P, Besra, G, Jones, E, Batista, F, Cerundolo, V